- Formosa Chemicals reported sales of NT$32.15 billion in April.
- The recorded sales for Formosa Chemicals indicated a 26% increase in sales.
- According to analysts, the company was issued with 2 ‘buy’ ratings.
- Apart from the ‘buy’ ratings, 8 analysts adopted a ‘hold’ stance on Formosa Chemicals.
- The company also received 3 ‘sell’ ratings from analysts.
A look at Formosa Chemicals & Fibre Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 5 | |
Dividend | 2 | |
Growth | 3 | |
Resilience | 3 | |
Momentum | 2 | |
OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
“`html
Formosa Chemicals & Fibre Corporation, a company that specializes in manufacturing and marketing petrochemical products, nylon fiber, and rayon staple fiber, is showing a promising long-term outlook based on the Smartkarma Smart Scores. With an impressive Value score of 5, the company is deemed to offer favorable investment opportunities relative to its market price. While its Dividend and Momentum scores stand at 2, suggesting room for improvement, the Growth and Resilience scores of 3 indicate a moderate outlook for future expansion and stability.
Formosa Chemicals & Fibre‘s strategic positioning in the petrochemical and fiber market, with a strong presence in Taiwan and Asia through exports, coupled with its solid Value score, suggests a resilient and potentially lucrative investment option in the long run. Although areas like Dividend and Momentum may require attention, the company’s overall outlook appears positive for investors looking for long-term growth potential.
“`
Summary: Formosa Chemicals & Fibre Corporation is a manufacturing company that focuses on producing and selling petrochemical products, nylon fiber, and rayon staple fiber. The company has a significant market presence in Taiwan and exports its products to various Asian regions.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars